Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawFetal Tissue, Stem Cells & Bioethics

CLI Vice Pres. Dr. Prentice on Human Embryo Genetic Manipulation: “Modest but Meaningful Protection”

 

On December 17, 2015, Townhall published an op-ed by CLI Vice President Dr. David Prentice on the only new pro-life item in the federal Omnibus funding bill. Rep. Robert Aderholt (R-Ala.) proposed language to the bill to prevent the approval of the creation or use of genetically-manipulated human embryos in a clinical setting.

 

Though the Dickey-Wicker Amendment, first enacted in 1996, already prohibits federal funding of research that creates or destroys a human embryo, says Dr. Prentice, this new language fills a gap in the process so that the Food and Drug Administration (FDA) is precluded from even entertaining approval of any research submissions “in which a human embryo is intentionally created or modified to include a heritable genetic modification.”

 

While the new language puts a pause on genetic experiments on human embryos, Dr. Prentice stresses that it “does not in any way hinder genetic therapies or trials for born individuals” and that it still allows “necessary research for authentic treatments to continue unabated.”

 

To read the full op-ed in Townhall, please see: https://townhall.com/columnists/davidaprentice/2015/12/17/modest-but-meaningful-protection-from-human-embryo-genetic-manipulation-n2094746

Latest Posts

May 29, 2024 Abortion Reporting: West Virginia (2023) May 29, 2024 Abortion Reporting: Indiana (2023) May 23, 2024 United Kingdom Data Deficiencies Influencing U.S. FDA Decisions United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

You Might Also Be Interested In

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

May 23, 2024
ClosePlease login

Misleading Statements About “Life of the Mother” Exceptions in Pro-life Laws Require Correction

Gestational Limits on Abortion in the United States Compared to International Norms (April 2024)

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image